Biomedicines (Aug 2023)

Lowered Delta Activity in Post-COVID-19 Patients with Fatigue and Cognitive Impairment

  • Paola Ortelli,
  • Angelica Quercia,
  • Antonio Cerasa,
  • Sabrina Dezi,
  • Davide Ferrazzoli,
  • Luca Sebastianelli,
  • Leopold Saltuari,
  • Viviana Versace,
  • Angelo Quartarone

DOI
https://doi.org/10.3390/biomedicines11082228
Journal volume & issue
Vol. 11, no. 8
p. 2228

Abstract

Read online

In post-COVID-19 syndrome (PCS), neurocognitive symptoms and fatigue are often associated with alterations in electroencephalographic (EEG) activity. The present study investigates the brain source activity at rest in PCS patients (PCS-pts) perceiving cognitive deficits and fatigue. A total of 18 PCS-pts and 18 healthy controls (HCs) were enrolled. A Montreal Cognitive Assessment (MoCA), Perceived Cognitive Difficulties Scale (PDCS) and Fatigue Severity Scale (FSS) were administered for assessing the symptoms’ severity. Brain activity at rest, both with open (OE) and closed eyes (CE), was recorded by high-density EEG (Hd-EEG) and localized by source estimation. Compared to HCs, PCS-pts exhibited worse performance in executive functions, language and memory, and reported higher levels of fatigue. At resting OE state, PCS-pts showed lower delta source activity over brain regions known to be associated with executive processes, and these changes were negatively associated with PDCS scores. Consistent with recent literature data, our findings could indicate a dysfunction in the neuronal networks involved in executive functions in PCS-pts complaining of fatigue and cognitive impairment.

Keywords